These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 15618931

  • 1. Patterns histopathologic of Fox-Fordyce disease.
    Böer A.
    Am J Dermatopathol; 2004 Dec; 26(6):482-92. PubMed ID: 15618931
    [Abstract] [Full Text] [Related]

  • 2. [Fox-Fordyce disease (apocrine miliaria)].
    Mayser P, Gründer K, Nilles M, Schill WB.
    Hautarzt; 1993 May; 44(5):309-11. PubMed ID: 8320118
    [Abstract] [Full Text] [Related]

  • 3. Perifollicular xanthomatosis as the hallmark of axillary Fox-Fordyce disease: an evaluation of histopathologic features of 7 cases.
    Bormate AB, Leboit PE, McCalmont TH.
    Arch Dermatol; 2008 Aug; 144(8):1020-4. PubMed ID: 18711075
    [Abstract] [Full Text] [Related]

  • 4. Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease.
    Kamada A, Saga K, Jimbow K.
    J Am Acad Dermatol; 2003 Mar; 48(3):453-5. PubMed ID: 12637930
    [Abstract] [Full Text] [Related]

  • 5. [Perifollicular xanthomatosis as a key histological finding in Fox-Fordyce disease].
    Mataix J, Silvestre JF, Niveiro M, Lucas A, Pérez-Crespo M.
    Actas Dermosifiliogr; 2008 Mar; 99(2):145-8. PubMed ID: 18346437
    [Abstract] [Full Text] [Related]

  • 6. Fox-Fordyce disease in two prepubertal girls: histopathologic demonstration of eccrine sweat gland involvement.
    Ranalletta M, Rositto A, Drut R.
    Pediatr Dermatol; 1996 Mar; 13(4):294-7. PubMed ID: 8844748
    [Abstract] [Full Text] [Related]

  • 7. Histopathology attributes of Fox-Fordyce disease.
    Brau Javier CN, Morales A, Sanchez JL.
    Int J Dermatol; 2012 Nov; 51(11):1313-8. PubMed ID: 23067079
    [Abstract] [Full Text] [Related]

  • 8. Clinical effects of topical pimecrolimus in a patient with Fox-Fordyce disease.
    Milcic D, Nikolic M.
    Australas J Dermatol; 2012 May; 53(2):e34-5. PubMed ID: 22571582
    [Abstract] [Full Text] [Related]

  • 9. Apocrine sweat retention in man. II. Fox-Fordyce disease (apocrine miliaria).
    SHELLEY WB, LEVY EJ.
    AMA Arch Derm; 1956 Jan; 73(1):38-49. PubMed ID: 13275123
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fox-Fordyce disease: diagnosis with transverse histologic sections.
    Stashower ME, Krivda SJ, Turiansky GW.
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):89-91. PubMed ID: 10607326
    [Abstract] [Full Text] [Related]

  • 15. Fox-Fordyce disease.
    Macmillan DC, Vickers HR.
    Br J Dermatol; 1971 Feb; 84(2):181. PubMed ID: 5548469
    [No Abstract] [Full Text] [Related]

  • 16. Fox-Fordyce disease.
    Yost J, Robinson M, Meehan SA.
    Dermatol Online J; 2012 Dec 15; 18(12):28. PubMed ID: 23286818
    [Abstract] [Full Text] [Related]

  • 17. Fox-Fordyce disease following axillary laser hair removal.
    Tetzlaff MT, Evans K, DeHoratius DM, Weiss R, Cotsarelis G, Elenitsas R.
    Arch Dermatol; 2011 May 15; 147(5):573-6. PubMed ID: 21576577
    [Abstract] [Full Text] [Related]

  • 18. Fox-Fordyce disease exacerbated by hyperhidrosis.
    Alikhan A, Gorouhi F, Zargari O.
    Pediatr Dermatol; 2010 May 15; 27(2):162-5. PubMed ID: 20537067
    [Abstract] [Full Text] [Related]

  • 19. Fox-Fordyce disease: response to adapalene 0.1%.
    Kassuga LE, Medrado MM, Chevrand NS, Salles Sde A, Vilar EG.
    An Bras Dermatol; 2012 May 15; 87(2):329-31. PubMed ID: 22570049
    [Abstract] [Full Text] [Related]

  • 20. Electron microscopic observation of Fox-Fordyce's disease.
    Shimizu H.
    Bull Pharm Res Inst; 1966 Jan 15; 60():7-13. PubMed ID: 6012859
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.